Security Name | Ticker | % of Net Assets |
---|---|---|
ELI LILLY & COMPANY | LLY | 4.17% |
JOHNSON & JOHNSON | JNJ | 2.96% |
ABBVIE INC | ABBV | 2.73% |
ABBOTT LABORATORIES | ABT | 2.44% |
INTUITIVE SURGICAL, INC. | ISRG | 2.27% |
UNITEDHEALTH GROUP INC. | UNH | 2.14% |
MERCK & COMPANY, INC. | MRK | 2.04% |
BOSTON SCIENTIFIC CORP | BSX | 1.95% |
AMGEN INC. | AMGN | 1.89% |
STRYKER CORP | SYK | 1.85% |
DANAHER CORPORATION | DHR | 1.81% |
GILEAD SCIENCES, INC. | GILD | 1.80% |
PFIZER INC | PFE | 1.80% |
THERMO FISHER SCIENTIFIC | TMO | 1.76% |
VERTEX PHARMACEUTICALS | VRTX | 1.60% |
MCKESSON CORPORATION | MCK | 1.56% |
THE CIGNA GROUP | CI | 1.45% |
BRISTOL MYERS SQUIBB CO | BMY | 1.44% |
ELEVANCE HEALTH INC | ANTM | 1.40% |
CVS HEALTH CORP. | CVS | 1.39% |
HCA HEALTCARE INC | HCA | 1.35% |
ZOETIS INC | ZTS | 1.33% |
CENCORA INC | ABC | 1.20% |
VEEVA SYSTEMS-A | VEEV | 1.16% |
IDEXX LABORATORIES INC | IDXX | 1.16% |
ASTRAZENECA PLC ADR | AZN | 1.14% |
EDWARDS LIFESCIENCES CORP | EW | 1.10% |
ALNYLAM PHARMACEUTICALS | ALNY | 1.08% |
NOVO-NORDISK A/S -ADR | NVO | 1.07% |
MEDTRONIC PLC | MDT | 1.06% |
CARDINAL HEALTH, INC. | CAH | 1.05% |
REGENERON PHARMACEUTICALS | REGN | 1.03% |
RESMED INC | RMD | 1.02% |
DEXCOM INC | DXCM | 0.99% |
BECTON DICKINSON & CO | BDX | 0.98% |
AGILENT TECHNOLOGIES, INC | A | 0.92% |
GE HEALTHCARE TECHNOLOGY | GEHC | 0.85% |
GSK PLC-SPON ADR | GSK-W | 0.83% |
INSULET CORP | PODD | 0.81% |
TEVA PHARMACEUTICAL | TEVA | 0.81% |
CENTENE CORP | CNC | 0.81% |
NATERA INC | NTRA | 0.80% |
STERIS PLC | STE | 0.80% |
HUMANA, INC. | HUM | 0.79% |
ICON PLC | ICLR | 0.79% |
NOVARTIS ADR | NVS | 0.77% |
LABCORP HOLDINGS INC | LH | 0.77% |
ARGENX SE - ADR | ARGX | 0.77% |
BIONTECH SE-ADR | BNTX | 0.77% |
IQVIA HOLDINGS INC | IQV | 0.77% |
INSMED INC | INSM | 0.76% |
TENET HEALTHCARE CORP | THC | 0.72% |
QUEST DIAGNOSTICS, INC. | DGX | 0.72% |
HIMS & HERS HEALTH INC | HIMS | 0.70% |
ALKERMES PLC | ALKS | 0.68% |
BIOGEN IDEC, INC. | BIIB | 0.68% |
CRISPR THERAPEUTICS AG | CRSP | 0.68% |
ROYALTY PHARMA PLC- CL A | RPRX | 0.66% |
ZIMMER BIOMET HOLDINGS IN | ZBH | 0.64% |
WEST PHARMACEUTICAL SERVI | WST | 0.63% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 0.62% |
ALIGN TECHNOLOGY | ALGN | 0.62% |
HOLOGIC, INC. | HOLX | 0.62% |
MOLINA HEALTHCARE INC | MOH | 0.61% |
BAXTER INTERNATIONAL | BAX | 0.60% |
ILLUMINA INC | ILMN | 0.60% |
EXACT SCIENCES | EXAS | 0.59% |
NEUROCRINE BIOSCIENCES IN | NBIX | 0.59% |
WATERS CORPORATION | WAT | 0.58% |
COOPER COS INC/THE | COO | 0.57% |
EXELIXIS, INC. | EXEL | 0.55% |
BLUEPRINT MEDICI | BPMC | 0.54% |
UNITED THERAPEUTICS CORP | UTHR | 0.53% |
UNIVERSAL HEALTH SERVICES | UHS | 0.53% |
INCYTE CORP | INCY | 0.52% |
TRANSMEDICS GROUP INC | TMDX | 0.51% |
VIATRIS INC | VTRS | 0.51% |
ENSIGN GROUP INC/THE | ENSG | 0.50% |
HEALTHEQUITY INC | HQY | 0.49% |
HENRY SCHEIN, INC. | HSIC | 0.47% |
BIOMARIN PHARMACEUTICAL | BMRN | 0.46% |
CORCEPT THERA | CORT | 0.46% |
MASIMO CORP | MASI | 0.44% |
BRIDGEBIO PHARMA INC | BBIO | 0.44% |
GUARDANT HEALTH INC | GH | 0.43% |
MODERNA INC | MRNA | 0.43% |
REVOLUTION MEDICINES INC | RVMD | 0.43% |
AVANTOR INC | AVTR | 0.43% |
CHARLES RIVER LAB INTER | CRL | 0.41% |
BIO-TECHNE CORP | TECH | 0.41% |
LEGEND BIOTECH CORP-ADR | LEGN | 0.40% |
MEDPACE HOLDINGS | MEDP | 0.40% |
IONIS PHARMACEUTICALS, IN | IONS | 0.39% |
HALOZYME THERAPEUTICS INC | HALO | 0.38% |
ADMA BIOLOGICS INC | ADMA | 0.37% |
DAVITA, INC | DVA | 0.37% |
TG THERAPEUTICS | TGTX | 0.36% |
MERIT MEDICAL SYSTEMS INC | MMSI | 0.36% |
ROIVANT SCIENCES LTD | ROIV | 0.36% |
OPTION CARE HEALTH INC | OPCH | 0.35% |
LANTHEUS HOLDING | LNTH | 0.32% |
REPLIGEN CORP | RGEN | 0.32% |
AXSOME THERAPEUT | AXSM | 0.31% |
PROCEPT BIOROBOTICS CORP | PRCT | 0.30% |
BRUKER CORP | BRKR | 0.30% |
DENTSPLY SIRONA, NC. | XRAY | 0.29% |
AVIDITY BIOSCIENCES INC | RNA | 0.29% |
VIKING THERAPEUTICS INC | VKTX | 0.27% |
CYTOKINETICS INC | CYTK | 0.27% |
CRINETICS PHARMACEUTICALS | CRNX | 0.26% |
VAXCYTE INC | PCVX | 0.23% |
TWIST BIOSCIENCE CORP | TWST | 0.21% |
ACADIA HEALTHCAR | ACHC | 0.20% |
TANDEM DIABETES CARE INC | TNDM | 0.20% |
MADRIGAL PHARMAC | MDGL | 0.20% |
APELLIS PHARMACE | APLS | 0.20% |
SAREPTA THERAPEU | SRPT | 0.18% |
KRYSTAL BIOTECH INC | KRYS | 0.16% |
NOVAVAX INC | NVAX | 0.15% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.10% |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.